(Q36788138)

English

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

scientific article published on 8 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course (English)

1 reference

Europe PubMed Central

16 August 2017

1 reference

based on heuristic

inferred from title

chronic idiopathic myelofibrosis

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

9

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

16 August 2017

Srdan Verstovsek

10

object named as

Srdan Verstovsek

1 reference

Europe PubMed Central

16 August 2017

Jorge Eduardo Cortes

4

object named as

Jorge Cortes

1 reference

Europe PubMed Central

16 August 2017

8

object named as

Sherry Pierce

1 reference

Europe PubMed Central

16 August 2017

Michael J. Keating

6

object named as

Michael J Keating

1 reference

Europe PubMed Central

16 August 2017

Constantine S. Tam

1

object named as

Constantine S Tam

1 reference

Europe PubMed Central

16 August 2017

Lynne V Abruzzo

2

object named as

Lynne V Abruzzo

1 reference

Europe PubMed Central

16 August 2017

author name string

Katherine I Lin

3

1 reference

Europe PubMed Central

16 August 2017

Alice Lynn

5

1 reference

Europe PubMed Central

16 August 2017

Deborah A Thomas

7

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

8 January 2009

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

113

1 reference

Europe PubMed Central

16 August 2017

18

1 reference

Europe PubMed Central

16 August 2017

4171-4178

1 reference

Europe PubMed Central

16 August 2017

Identification of RPS14 as a 5q- syndrome gene by RNA interference screen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis resear

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Clonal evolution in chronic myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Deletions of chromosome 20q and the pathogenesis of myeloproliferative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

29 September 2017

Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

27 June 2018

Polycythemia vera is not initiated by JAK2V617F mutation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

5 September 2018

Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

5 September 2018

Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

5 September 2018

Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

5 September 2018

Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

5 September 2018

Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4828077

4 December 2018

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic analysis of chromosome 13 deletions in BCR/ABL negative chronic myeloproliferative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosome studies in 104 patients with polycythemia vera

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/19131547

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-09-178541

1 reference

Europe PubMed Central

16 August 2017

0 references

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36788138&oldid=1744044618"